Home Shire launches “Rare Count” campaign to personalize global impact of rare diseases Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
Shire Plc’s U.K. Offices As Drugmaker Rejects Abbvie Inc.’s $46.5 Billion Offer
